1. Home
  2. CLNE vs MYGN Comparison

CLNE vs MYGN Comparison

Compare CLNE & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clean Energy Fuels Corp.

CLNE

Clean Energy Fuels Corp.

HOLD

Current Price

$2.15

Market Cap

478.4M

Sector

Utilities

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.71

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLNE
MYGN
Founded
2001
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
478.4M
481.6M
IPO Year
2006
1996

Fundamental Metrics

Financial Performance
Metric
CLNE
MYGN
Price
$2.15
$4.71
Analyst Decision
Strong Buy
Buy
Analyst Count
4
8
Target Price
$3.49
$7.64
AVG Volume (30 Days)
996.5K
1.6M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$341,599,000.00
$771,400,000.00
Revenue This Year
$5.99
$7.19
Revenue Next Year
$17.00
$5.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.33
52 Week Low
$1.30
$3.76
52 Week High
$3.11
$10.30

Technical Indicators

Market Signals
Indicator
CLNE
MYGN
Relative Strength Index (RSI) 37.85 43.84
Support Level $2.11 $3.93
Resistance Level $2.26 $5.63
Average True Range (ATR) 0.10 0.35
MACD -0.02 0.01
Stochastic Oscillator 12.31 30.77

Price Performance

Historical Comparison
CLNE
MYGN

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas and liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The firm operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. It also builds, operates, and maintains natural gas fueling stations for customers.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: